Another excellent article from the Guardian on Lon
Post# of 145810
https://www.theguardian.com/society/2022/oct/...es-studies
The drug that can cure the symptom of "fatigue" as well as "malaise" and "brain fog" will be a Blockbuster. Why shouldn't it be Leronlimab? Enormous personal and social benefits!
Can it really be that hard to design a trial here? Enrollment should be easy!
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)